Insulet (NASDAQ:PODD) Stock, Unusual Options

Insulet

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Government Trades

Stock Report

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Comments

Insulet Unusual Options